Periodontal Disease Treatment Market - Global Forecast To 2030
商品番号 : SMB-70029
| 出版社 | MarketsandMarkets |
| 出版年月 | 2024年11月 |
| ページ数 | 280 |
| 図表数 | 357 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The global Periodontal disease treatment Equipment market is projected to reach USD 3.63 billion by 2030 from USD 2.58 billion in 2024, at a CAGR of 5.9% during the forecast period.
世界の歯周病治療機器市場は、2024年の25億8,000万米ドルから2030年までに36億3,000万米ドルに達すると予測されており、予測期間中のCAGRは5.9%です。
This is due to increased awareness about the connection between oral health and overall systemic health, bringing the focus of both the patients and healthcare provider towards periodontal care. Increased government-driven campaigns to promote hygiene in the oral cavity and increased provision of dental insurance coverage have also added momentum towards this market. The increase in dental care infrastructures, especially in developing economies, is further fueling this market. In addition, the adoption of minimally invasive procedures and biologics as well as the discovery of new drugs has increased the efficacy of treatment, adding more fuel to the growth of the periodontal disease market players over the forecast period of 2024-2030.
“The chronic periodontitis segment of periodontal disease treatment market to hold second largest position forecast period.”
Based on the disease type, the chronic periodontitis segment is anticipated to hold second largest share position during forecast period in periodontal disease treatment equipment market. This is due to increasing number of older populations are suffering from periodontal diseases. The condition will become increasingly common since chronic periodontitis is often found in older patients. Enhanced awareness regarding the relationship between oral health and systemic conditions, such as diabetes mellitus and cardiovascular disease, is generating a greater demand among patients to receive preventive and therapeutic care, which is increasing diagnoses and subsequent treatment adoption.
“The guided tissue regeneration segment is the fastest growing segment in periodontal disease treatment market.”
Based on treatment type, the periodontal disease treatment market is segmented into non-surgical treatment, flap surgery, soft tissue graft, bone grafting, guided tissue regeneration and other treatments. The guided tissue regeneration segment is expected to grow at the highest CAGR due to its pivotal role in periodontal disease treatment research and development (R&D). Advances in biomaterials and tissue engineering have been made, leading to newer and more efficient and biocompatible membranes with better outcomes. GTR procedures are increasingly being adopted by dental professionals, and their growing training and availability of specialized equipment have made it highly potential. Favorable reimbursement policies in different regions coupled with an upsurge of cosmetic dentistry have also played an important role in the high growth rate of the GTR market.
“Europe accounted for the second largest share of the periodontal disease treatment market by region.”
The global periodontal disease treatment equipment market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe is the second largest regional market for periodontal disease treatment equipment, whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.
Europe holds the second-largest position in the periodontal disease treatment equipment market. The region has a well-established health infrastructure which provides better access to advanced dental care. Moreover, the significant rise in the geriatric population, which is more prone to periodontal diseases, covers the majority of the treatments required in Europe. The high awareness of oral health and preventive care services available in European countries further spur the expansion of this market. Favorable government policies, and reimbursement frameworks for dental care treatments, along with a high dental insurance coverage among the patients, supports them toward getting periodontal treatments. Ongoing research and development in dental technologies and biomaterials, including countries like Germany and Switzerland, also support this expansion in this region.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–40%, Tier 2–30%, and Tier 3– 30%
- By Designation: Directors–50%, Managers–30% and Others–20%
- By Region: North America–38%, Europe–26%, Asia Pacific–15%, Latin America–11%, Middle East & Africa- 7%, GCC Countries- 3%
The major players operating in the periodontal disease treatment equipment market market are DENTSPLY SIRONA Inc. (US), Envista Holdings Corporation (US), A-dec Inc. (US), J. MORITA CORP. (Japan), Straumann Group (Switzerland), BIOLASE, Inc. (US), BEGO GmbH & Co. KG (Germany), Ultradent Products, Inc. (US), Yoshida Dental MFG. Co., Ltd. (Japan), Nakanishi Inc. (Japan), DentalEZ, Inc. (US), Geistlich Pharma AG (Switzerland), Nova Instruments (UK), NewTom (Italy), Millennium Dental Technologies, Inc. (US), PreXion, Inc. (Japan), Brasseler USA (US), AMD Lasers (US), and Bien-Air Dental (US).
Research Coverage
This report studies the periodontal disease treatment equipment market based on disease type, streatment type, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
- Analysis of Key divers( Development of technologically advanced solutions, Rise in oral health disorders, Rising demand for advanced cosmetic dental procedures, Growing market for dental tourism in emerging countries restraints (High cost of dental imaging systems and lack of reimbursement for dental procedures, opportunity (Impact of DSOs on dental industry, Increasing number of dental laboratories investing in CAD/CAM technologies and Growing focus on emerging markets)
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the periodontal disease treatment market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the periodontal disease treatment market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the periodontal disease treatment market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
Table of Contents
1 INTRODUCTION 27
1.1 STUDY OBJECTIVES 27
1.2 MARKET DEFINITION 27
1.3 MARKET SCOPE 28
1.3.1 MARKET SEGMENTATION 28
1.3.2 INCLUSIONS & EXCLUSIONS 29
1.3.3 YEARS CONSIDERED 29
1.3.4 CURRENCY CONSIDERED 29
1.4 MARKET STAKEHOLDERS 30
2 RESEARCH METHODOLOGY 31
2.1 RESEARCH DATA 31
2.1.1 SECONDARY DATA 32
2.1.1.1 Key data from secondary sources 33
2.1.2 PRIMARY DATA 33
2.1.2.1 Key data from primary sources 34
2.1.2.2 Key industry insights 35
2.2 MARKET SIZE ESTIMATION 37
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 42
2.4 MARKET SHARE ASSUMPTIONS 43
2.5 RISK ASSESSMENT 44
2.6 RESEARCH LIMITATIONS 44
2.6.1 METHODOLOGY-RELATED LIMITATIONS 44
3 EXECUTIVE SUMMARY 45
4 PREMIUM INSIGHTS 49
4.1 PERIODONTAL DISEASE TREATMENT MARKET OVERVIEW 49
4.2 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET,
BY END USER & COUNTRY (2023) 50
4.3 PERIODONTAL DISEASE TREATMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 51
4.4 REGIONAL MIX: PERIODONTAL DISEASE TREATMENT MARKET (2024−2030) 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
5.2.1 DRIVERS 53
5.2.1.1 Increasing prevalence of oral disorders 53
5.2.1.2 Rising cases of edentulism 53
5.2.1.3 Emergence of innovative dental treatment procedures 54
5.2.1.4 Expanding market for dental tourism in emerging economies 55
5.2.2 RESTRAINTS 56
5.2.2.1 High cost of advanced treatments and inadequate reimbursements for dental procedures 56
5.2.3 OPPORTUNITIES 56
5.2.3.1 Impact of DSOs on dental industry 56
5.2.3.2 Growing awareness about oral health 58
5.2.4 CHALLENGES 59
5.2.4.1 Shortage of skilled dental practitioners 59
5.3 INDUSTRY TRENDS 59
5.3.1 INCREASING PREFERENCE OF MINIMALLY INVASIVE DENTAL PROCEDURES 59
5.3.2 MARKET CONSOLIDATION 60
5.3.3 DENTAL INSURANCE IN US 60
5.4 TECHNOLOGY ANALYSIS 61
5.4.1 KEY TECHNOLOGIES 61
5.4.1.1 3D printers 61
5.4.1.2 Artificial intelligence 61
5.4.2 ADJACENT TECHNOLOGIES 62
5.4.2.1 Virtual reality 62
5.4.2.2 Laser dentistry 62
5.5 VALUE CHAIN ANALYSIS 62
5.6 ECOSYSTEM MAP 63
5.7 SUPPLY CHAIN ANALYSIS 64
5.8 REGULATORY ANALYSIS 64
5.8.1 REGULATORY LANDSCAPE 64
5.8.1.1 US 64
5.8.1.2 EU 65
5.8.1.3 China 66
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
5.9 PATENT ANALYSIS 69
5.9.1 PATENT PUBLICATION TRENDS FOR PERIODONTAL DISEASE TREATMENT 69
5.9.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 70
5.10 TRADE ANALYSIS 72
5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 74
5.12 ADJACENT MARKETS FOR PERIODONTAL DISEASE TREATMENT 75
5.13 CASE STUDY ANALYSIS 75
5.13.1 CASE STUDY 1: INNOVATION TRACKING, TECHNOLOGY ASSESSMENT, AND PRODUCT LAUNCHES IN ANTIMICROBIAL AGENTS & COATING SUBSTANCES FOR DENTAL IMPLANTS 75
5.13.2 CASE STUDY 2: CUSTOMIZED STUDY FOR MEA 76
5.13.3 CASE STUDY 3: CUSTOMIZED STUDY FOR LATIN AMERICA 76
5.14 PORTER’S FIVE FORCES ANALYSIS 77
5.14.1 THREAT OF NEW ENTRANTS 78
5.14.2 THREAT OF SUBSTITUTES 78
5.14.3 BARGAINING POWER OF SUPPLIERS 78
5.14.4 BARGAINING POWER OF BUYERS 78
5.14.5 INTENSITY OF COMPETITIVE RIVALRY 79
5.15 KEY CONFERENCES & EVENTS, 2024 79
5.16 PRICING ANALYSIS 80
5.16.1 AVERAGE COST OF PERIODONTAL DISEASE TREATMENT SYSTEMS (2021−2023) (USD) 80
5.16.2 AVERAGE COST RANGE OF PERIODONTAL DISEASE TREATMENT, BY REGION (2021−2023) (USD) 80
5.16.3 AVERAGE SELLING PRICE OF PERIODONTAL DISEASE TREATMENT,
BY PRODUCT TYPE 81
5.17 KEY STAKEHOLDERS AND BUYING CRITERIA 81
5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS 81
5.17.2 BUYING CRITERIA 82
5.18 UNMET NEEDS IN PERIODONTAL DISEASE TREATMENT MARKET 83
5.19 INVESTMENT & FUNDING SCENARIO 84
5.20 PREVALENCE OF GINGIVAL CASES IN KEY COUNTRIES 84
5.21 ANALYSIS OF TOTAL NUMBER OF SURGERIES IN KEY COUNTRIES 85
6 PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT 86
6.1 INTRODUCTION 87
6.2 EQUIPMENT 87
6.2.1 GROWING PREFERENCE FOR MIS PROCEDURES TO DRIVE MARKET 87
6.3 CONSUMABLES 88
6.3.1 RECURRING NATURE & FREQUENT PURCHASE TO PROPEL MARKET 88
6.4 MEDICATION 90
6.4.1 GROWING AWARENESS OF ORAL HEALTH AND IMPROVEMENTS IN ANTIBIOTICS TO SUPPORT MARKET 90
7 PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE 92
7.1 INTRODUCTION 93
7.2 GINGIVITIS 93
7.2.1 ACUTE GINGIVITIS 95
7.2.1.1 Prevalence in children and adolescents to drive market 95
7.2.2 RECURRENT GINGIVITIS 96
7.2.2.1 Recurrent cases of bacterial infection due to poor oral hygiene to fuel market 96
7.2.3 CHRONIC GINGIVITIS 97
7.2.3.1 Prolonged inflammation of gums to support market growth 97
7.3 CHRONIC PERIODONTITIS 98
7.3.1 INCREASING CASES OF EDENTULISM TO FUEL MARKET 98
7.4 AGGRESSIVE PERIODONTITIS 100
7.4.1 RAPID TOOTH LOSS AND UNDERLYING HEALTH CONDITIONS TO CONTRIBUTE TO MARKET GROWTH 100
7.5 OTHER DISEASES 101
8 PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT 103
8.1 INTRODUCTION 104
8.2 NON-SURGICAL TREATMENT 104
8.2.1 SCALING 106
8.2.1.1 Ability to inhibit bacterial infection to fuel uptake 106
8.2.2 ROOT PLANING 107
8.2.2.1 Reduction of gingival pockets to support market growth 107
8.2.3 MEDICATION THERAPY 109
8.2.3.1 Topical therapy 110
8.2.3.1.1 Uptake of antimicrobial gels and mouth rinses to drive market 110
8.2.3.2 Systemic therapy 112
8.2.3.2.1 Utilization of host-modulating agents and antibiotics to drive market 112
8.3 FLAP SURGERY/POCKET REDUCTION THERAPY 113
8.3.1 COMMON SURGICAL PROCEDURE FOR ADVANCED PERIODONTAL DISEASES TO DRIVE MARKET 113
8.4 SOFT TISSUE GRAFT 114
8.4.1 PREVALENCE OF GINGIVAL RECESSION TO FUEL UPTAKE 114
8.5 BONE GRAFTING 115
8.5.1 GROWING FOCUS ON REGENERATION OF BONES TO FUEL UPTAKE 115
8.6 GUIDED TISSUE REGENERATION 117
8.6.1 HIGH SUCCESS RATE TO PROPEL MARKET 117
8.7 OTHER TREATMENTS 118
9 PERIODONTAL DISEASE TREATMENT MARKET, BY END USER 119
9.1 INTRODUCTION 120
9.2 HOSPITALS 120
9.2.1 AVAILABILITY OF ADVANCED EQUIPMENT FOR DENTISTRY AND GROWING FOCUS ON DENTAL TOURISM TO PROPEL MARKET 120
9.3 PRIVATE & DSO CLINICS 122
9.3.1 INCREASING ESTABLISHMENT OF PRIVATE PRACTICES TO DRIVE MARKET 122
9.4 ACADEMIC & RESEARCH INSTITUTES 124
9.4.1 R&D FUNDING INITIATIVES TO SUPPORT MARKET GROWTH 124
10 PERIODONTAL DISEASE TREATMENT MARKET, BY REGION 126
10.1 INTRODUCTION 127
10.2 NORTH AMERICA 127
10.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK 128
10.2.2 US 131
10.2.2.1 Favorable reimbursement policies for dental procedures to drive market 131
10.2.3 CANADA 134
10.2.3.1 Rising incidence of dental caries to drive market 134
10.3 EUROPE 138
10.3.1 EUROPE: MACROECONOMIC OUTLOOK 141
10.3.2 GERMANY 141
10.3.2.1 Hub for advanced dentistry technologies to propel market 141
10.3.3 FRANCE 145
10.3.3.1 Favorable government healthcare policies to fuel uptake 145
10.3.4 UK 148
10.3.4.1 Increasing incidence of dental disorders to drive market 148
10.3.5 ITALY 151
10.3.5.1 Low-cost dental treatments to support market growth 151
10.3.6 SPAIN 154
10.3.6.1 Privatization of dental clinics and uptake of advanced technologies to support market growth 154
10.3.7 REST OF EUROPE 158
10.4 ASIA PACIFIC 161
10.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK 162
10.4.2 CHINA 165
10.4.2.1 Growing prevalence of dental diseases to drive market growth in China 165
10.4.3 JAPAN 168
10.4.3.1 Rising geriatric population and favorable reimbursement scenario to support market growth 168
10.4.4 INDIA 171
10.4.4.1 Expansion of dentistry and growing awareness of oral hygiene to drive market 171
10.4.5 AUSTRALIA 175
10.4.5.1 Favorable government initiatives and growing prevalence of dental diseases to drive market 175
10.4.6 SOUTH KOREA 178
10.4.6.1 Increasing cases of edentulism to fuel uptake 178
10.4.7 REST OF ASIA PACIFIC 181
10.5 LATIN AMERICA 184
10.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK 184
10.5.2 MEXICO 187
10.5.2.1 Growth in dental tourism to drive market 187
10.5.3 BRAZIL 191
10.5.3.1 Trend of cosmetic dentistry to propel market 191
10.5.4 ARGENTINA 194
10.5.4.1 increasing use of CAD/CAM systems to support market growth 194
10.5.5 REST OF LATIN AMERICA 197
10.6 MIDDLE EAST & AFRICA 200
10.6.1 RISING AWARENESS ABOUT DENTAL HYGIENE TO SUPPORT MARKET GROWTH 200
10.6.2 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 200
10.7 GCC COUNTRIES 203
10.7.1 GROWING DEMAND FOR PERSONALIZED DENTISTRY TO DRIVE MARKET 203
10.7.2 GCC COUNTRIES: MACROECONOMIC OUTLOOK 203
11 COMPETITIVE LANDSCAPE 207
11.1 INTRODUCTION 207
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN 207
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PERIODONTAL DISEASE TREATMENT MARKET 208
11.3 REVENUE ANALYSIS, 2019−2023 209
11.4 MARKET SHARE ANALYSIS, 2023 209
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 212
11.5.1 STARS 212
11.5.2 EMERGING LEADERS 212
11.5.3 PERVASIVE PLAYERS 212
11.5.4 PARTICIPANTS 212
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 214
11.5.5.1 Company footprint 214
11.5.5.2 Region footprint 215
11.5.5.3 Product footprint 216
11.5.5.4 Disease footprint 217
11.5.5.5 Treatment footprint 218
11.5.5.6 End-user footprint 219
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 220
11.6.1 PROGRESSIVE COMPANIES 220
11.6.2 RESPONSIVE COMPANIES 220
11.6.3 DYNAMIC COMPANIES 220
11.6.4 STARTING BLOCKS 220
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 222
11.7 COMPANY VALUATION & FINANCIAL METRICS 223
11.7.1 FINANCIAL METRICS 223
11.7.2 COMPANY VALUATION 223
11.8 BRAND/PRODUCT COMPARISON 224
11.9 R&D EXPENDITURE 225
11.10 COMPETITIVE SCENARIO 225
11.10.1 PRODUCT LAUNCHES & APPROVALS 225
11.10.2 DEALS 226
11.10.3 EXPANSIONS 227
12 COMPANY PROFILES 228
12.1 KEY PLAYERS 228
12.1.1 DENTSPLY SIRONA 228
12.1.1.1 Business overview 228
12.1.1.2 Products offered 230
12.1.1.3 Recent developments 231
12.1.1.3.1 Product launches 231
12.1.1.3.2 Deals 231
12.1.1.4 MnM view 232
12.1.1.4.1 Key strengths 232
12.1.1.4.2 Strategic choices 232
12.1.1.4.3 Weaknesses & competitive threats 232
12.1.2 ENVISTA HOLDINGS CORPORATION 233
12.1.2.1 Business overview 233
12.1.2.2 Products offered 234
12.1.2.3 Recent developments 235
12.1.2.3.2 Product approvals 235
12.1.2.3.3 Deals 235
12.1.2.4 MnM view 236
12.1.2.4.1 Key strengths 236
12.1.2.4.2 Strategic choices 236
12.1.2.4.3 Weaknesses & competitive threats 236
12.1.3 INSTITUT STRAUMANN AG 237
12.1.3.1 Business overview 237
12.1.3.2 Products offered 238
12.1.3.3 Recent developments 239
12.1.3.3.1 Product launches 239
12.1.3.3.2 Deals 239
12.1.3.3.3 Expansions 239
12.1.3.4 MnM view 240
12.1.3.4.1 Key strengths 240
12.1.3.4.2 Strategic choices 240
12.1.3.4.3 Weaknesses & competitive threats 240
12.1.4 HENRY SCHEIN, INC. 241
12.1.4.1 Business overview 241
12.1.4.2 Products offered 242
12.1.4.3 Recent developments 243
12.1.4.3.1 Deals 243
12.1.4.4 MnM view 244
12.1.4.4.1 Key strengths 244
12.1.4.4.2 Strategic choices 244
12.1.4.4.3 Weaknesses & competitive threats 244
12.1.5 BIOLASE, INC. 245
12.1.5.1 Business overview 245
12.1.5.2 Products offered 246
12.1.5.3 Recent developments 247
12.1.5.3.1 Product launches 247
12.1.6 GEISTLICH PHARMA AG 248
12.1.6.1 Business overview 248
12.1.6.2 Products offered 248
12.1.7 J. MORITA CORP. 249
12.1.7.1 Business overview 249
12.1.7.2 Products offered 249
12.1.7.3 Recent developments 250
12.1.7.3.1 Product launches 250
12.1.7.3.2 Deals 250
12.1.8 NAKANISHI INC. 251
12.1.8.1 Business overview 251
12.1.8.2 Products offered 252
12.1.9 A-DEC INC. 253
12.1.9.1 Business overview 253
12.1.9.2 Products offered 253
12.1.10 RTI SURGICAL 254
12.1.10.1 Business overview 254
12.1.10.2 Products offered 254
12.1.10.3 Recent developments 255
12.1.10.3.1 Deals 255
12.1.11 YOSHIDA DENTAL MFG.CO. LTD. 256
12.1.11.1 Business overview 256
12.1.11.2 Products offered 256
12.1.12 KEYSTONE DENTAL INC. 257
12.1.12.1 Business overview 257
12.1.12.2 Products offered 257
12.1.12.3 Recent developments 258
12.1.12.3.1 Deals 258
12.1.13 ULTRADENT PRODUCTS, INC. 259
12.1.13.1 Business overview 259
12.1.13.2 Products offered 259
12.1.14 BEGO GMBH & CO. KG 260
12.1.14.1 Business overview 260
12.1.14.2 Products offered 260
12.1.14.3 Recent developments 261
12.1.14.3.1 Deals 261
12.1.15 DENTALEZ INC. 262
12.1.15.1 Business overview 262
12.1.15.2 Products offered 262
12.1.15.3 Recent developments 263
12.1.15.3.1 Product launches 263
12.1.16 PARKELL, INC. 264
12.1.16.1 Business overview 264
12.1.16.2 Products offered 264
12.1.16.3 Recent developments 265
12.1.16.3.1 Product launches 265
12.2 OTHER PLAYERS 266
12.2.1 MILLENNIUM DENTAL TECHNOLOGIES INC. 266
12.2.2 BRASSELER USA 266
12.2.3 AMD LASERS 267
12.2.4 NOVA INSTRUMENTS 267
12.2.5 BOTISS BIOMATERIALS GMBH 268
12.2.6 CONVERGENT DENTAL 268
12.2.7 NOVABONE 269
12.2.8 REGENITY 270
12.2.9 HANNOX INTERNATIONAL CORP. 270
13 APPENDIX 271
13.1 DISCUSSION GUIDE 271
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 276
13.3 CUSTOMIZATION OPTIONS 278
13.4 RELATED REPORTS 278
13.5 AUTHOR DETAILS 279
LIST OF TABLES
TABLE 1 CURRENCY CONVERSION RATE, 2019–2023 (UNIT OF USD) 30
TABLE 2 PERIODONTAL DISEASE TREATMENT MARKET: RISK ASSESSMENT ANALYSIS 44
TABLE 3 INCREASE IN GERIATRIC POPULATION, BY COUNTRY (2022) 53
TABLE 4 AVERAGE PROCEDURAL COSTS IN TOP TEN DENTAL
TOURISM DESTINATIONS (USD) 55
TABLE 5 LIST OF RECENT DEALS BY PRIVATE EQUITIES IN US, 2020–2023 57
TABLE 6 PER CAPITA NATIONAL INCOME, 2000–2020 (USD) 59
TABLE 7 KEY ACQUISITIONS (2019−2024) 60
TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68
TABLE 11 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
TABLE 12 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
TABLE 13 PERIODONTAL DISEASE TREATMENT: LIST OF MAJOR PATENTS 71
TABLE 14 US PERIODONTAL DISEASE TREATMENT AND SUPPLIES: EXPORTS,
2015–2022 (IN 000’) 73
TABLE 15 US INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, DENTAL OR VETERINARY SCIENCES: EXPORTS, 2019–2022 (IN 000’) 73
TABLE 16 PERIODONTAL DISEASE TREATMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 77
TABLE 17 KEY CONFERENCES & EVENTS, 2024 79
TABLE 18 AVERAGE COST OF PERIODONTAL DISEASE TREATMENT SYSTEMS,
(2021−2023) (USD) 80
TABLE 19 AVERAGE COST RANGE OF PERIODONTAL DISEASE TREATMENT, BY REGION (2021−2023) (USD) 80
TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PERIODONTAL DISEASE TREATMENT 82
TABLE 21 PERIODONTAL DISEASE TREATMENT MARKET: UNMET NEEDS 83
TABLE 22 IMPACT OF AI/GEN AI ON PERIODONTAL DISEASE TREATMENT MARKET 83
TABLE 23 PERIODONTAL DISEASE TREATMENT MARKET: PREVALENCE OF GINGIVITIS,
BY KEY COUNTRIES 84
TABLE 24 PERIODONTAL DISEASE TREATMENT MARKET: ANALYSIS OF TOTAL SURGERIES,
BY KEY COUNTRY 85
TABLE 25 PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 87
TABLE 26 PERIODONTAL DISEASE TREATMENT MARKET FOR EQUIPMENT, BY COUNTRY, 2022–2030 (USD MILLION) 88
TABLE 27 PERIODONTAL DISEASE TREATMENT MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2030 (USD MILLION) 89
TABLE 28 PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION, BY COUNTRY, 2022–2030 (USD MILLION) 91
TABLE 29 PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE,
2022–2030 (USD MILLION) 93
TABLE 30 GINGIVITIS MARKET, BY TYPE, 2022–2030 (USD MILLION) 94
TABLE 31 GINGIVITIS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 94
TABLE 32 ACUTE GINGIVITIS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 95
TABLE 33 RECURRENT GINGIVITIS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 97
TABLE 34 CHRONIC GINGIVITIS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 98
TABLE 35 CHRONIC PERIODONTITIS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 99
TABLE 36 AGGRESSIVE PERIODONTITIS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 101
TABLE 37 OTHER DISEASES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 102
TABLE 38 PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT,
2022–2030 (USD MILLION) 104
TABLE 39 NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION) 105
TABLE 40 NON-SURGICAL TREATMENT MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 105
TABLE 41 NON-SURGICAL TREATMENT MARKET FOR SCALING, BY COUNTRY,
2022–2030 (USD MILLION) 107
TABLE 42 NON-SURGICAL TREATMENT MARKET FOR ROOT PLANING, BY COUNTRY,
2022–2030 (USD MILLION) 108
TABLE 43 NON-SURGICAL TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE,
2022–2030 (USD MILLION) 109
TABLE 44 NON-SURGICAL TREATMENT MARKET FOR MEDICATION THERAPY, BY COUNTRY, 2022–2030 (USD MILLION) 110
TABLE 45 TOPICAL THERAPY MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 111
TABLE 46 SYSTEMIC THERAPY MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 113
TABLE 47 FLAP SURGERY/POCKET REDUCTION THERAPY MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 114
TABLE 48 SOFT TISSUE GRAFT MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 115
TABLE 49 BONE GRAFTING MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 116
TABLE 50 GUIDED TISSUE REGENERATION MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 117
TABLE 51 OTHER TREATMENTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 118
TABLE 52 PERIODONTAL DISEASE TREATMENT MARKET, BY END USER,
2022–2030 (USD MILLION) 120
TABLE 53 LEADING DESTINATIONS FOR COST-EFFICIENT DENTAL TREATMENT 121
TABLE 54 PERIODONTAL DISEASE TREATMENT MARKET FOR HOSPITALS, BY COUNTRY, 2022–2030 (USD MILLION) 122
TABLE 55 PERIODONTAL DISEASE TREATMENT MARKET FOR PRIVATE & DSO CLINICS,
BY COUNTRY, 2022–2030 (USD MILLION) 123
TABLE 56 PERIODONTAL DISEASE TREATMENT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2030 (USD MILLION) 125
TABLE 57 PERIODONTAL DISEASE TREATMENT MARKET, BY REGION, 2022–2030 (USD MILLION) 127
TABLE 58 NORTH AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 129
TABLE 59 NORTH AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 129
TABLE 60 NORTH AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION) 129
TABLE 61 NORTH AMERICA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION) 130
TABLE 62 NORTH AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION) 130
TABLE 63 NORTH AMERICA: NON-SURGICAL TREATMENT MARKET, BY TYPE,
2022–2030 (USD MILLION) 130
TABLE 64 NORTH AMERICA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 131
TABLE 65 NORTH AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION) 131
TABLE 66 US: MACROECONOMIC INDICATORS 132
TABLE 67 US: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 132
TABLE 68 US: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE,
2022–2030 (USD MILLION) 132
TABLE 69 US: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION) 133
TABLE 70 US: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT TYPE,
2022–2030 (USD MILLION) 133
TABLE 71 US: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION) 133
TABLE 72 US: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY,
BY TYPE, 2022–2030 (USD MILLION) 134
TABLE 73 US: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER,
2022–2030 (USD MILLION) 134
TABLE 74 CANADA: MACROECONOMIC INDICATORS 135
TABLE 75 CANADA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 135
TABLE 76 CANADA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE,
2022–2030 (USD MILLION) 135
TABLE 77 CANADA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION) 136
TABLE 78 CANADA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT,
2022–2030 (USD MILLION) 136
TABLE 79 CANADA: NON-SURGICAL TREATMENT MARKET, BY TYPE,
2022–2030 (USD MILLION) 136
TABLE 80 CANADA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 137
TABLE 81 CANADA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER,
2022–2030 (USD MILLION) 137
TABLE 82 EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 138
TABLE 83 EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 138
TABLE 84 EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE,
2022–2030 (USD MILLION) 139
TABLE 85 EUROPE: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION) 139
TABLE 86 EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT,
2022–2030 (USD MILLION) 140
TABLE 87 EUROPE: NON-SURGICAL TREATMENT MARKET, BY TYPE,
2022–2030 (USD MILLION) 140
TABLE 88 EUROPE: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 140
TABLE 89 EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER,
2022–2030 (USD MILLION) 141
TABLE 90 GERMANY: MACROECONOMIC INDICATORS 142
TABLE 91 GERMANY: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 142
TABLE 92 GERMANY: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE,
2022–2030 (USD MILLION) 143
TABLE 93 GERMANY: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS,
BY TYPE, 2022–2030 (USD MILLION) 143
TABLE 94 GERMANY: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT,
2022–2030 (USD MILLION) 144
TABLE 95 GERMANY: NON-SURGICAL TREATMENT MARKET, BY TYPE,
2022–2030 (USD MILLION) 144
TABLE 96 GERMANY: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 144
TABLE 97 GERMANY: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER,
2022–2030 (USD MILLION) 145
TABLE 98 FRANCE: MACROECONOMIC INDICATORS 146
TABLE 99 FRANCE: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 146
TABLE 100 FRANCE: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE,
2022–2030 (USD MILLION) 146
TABLE 101 FRANCE: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION) 147
TABLE 102 FRANCE: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT TYPE, 2022–2030 (USD MILLION) 147
TABLE 103 FRANCE: NON-SURGICAL TREATMENT MARKET, BY TYPE,
2022–2030 (USD MILLION) 147
TABLE 104 FRANCE: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 148
TABLE 105 FRANCE: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER,
2022–2030 (USD MILLION) 148
TABLE 106 UK: MACROECONOMIC INDICATORS 149
TABLE 107 UK: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 149
TABLE 108 UK: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE,
2022–2030 (USD MILLION) 149
TABLE 109 UK: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION) 150
TABLE 110 UK: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT,
2022–2030 (USD MILLION) 150
TABLE 111 UK: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION) 150
TABLE 112 UK: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY,
BY TYPE, 2022–2030 (USD MILLION) 151
TABLE 113 UK: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER,
2022–2030 (USD MILLION) 151
TABLE 114 ITALY: MACROECONOMIC INDICATORS 152
TABLE 115 ITALY: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 152
TABLE 116 ITALY: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE,
2022–2030 (USD MILLION) 152
TABLE 117 ITALY: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION) 153
TABLE 118 ITALY: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT,
2022–2030 (USD MILLION) 153
TABLE 119 ITALY: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION) 153
TABLE 120 ITALY: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 154
TABLE 121 ITALY: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER,
2022–2030 (USD MILLION) 154
TABLE 122 SPAIN: MACROECONOMIC INDICATORS 155
TABLE 123 SPAIN: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 155
TABLE 124 SPAIN: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE,
2022–2030 (USD MILLION) 156
TABLE 125 SPAIN: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION) 156
TABLE 126 SPAIN: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT,
2022–2030 (USD MILLION) 157
TABLE 127 SPAIN: NON-SURGICAL TREATMENT MARKET, BY TYPE,
2022–2030 (USD MILLION) 157
TABLE 128 SPAIN: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 157
TABLE 129 SPAIN: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER,
2022–2030 (USD MILLION) 158
TABLE 130 REST OF EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 159
TABLE 131 REST OF EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION) 159
TABLE 132 REST OF EUROPE: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION) 159
TABLE 133 REST OF EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION) 160
TABLE 134 REST OF EUROPE: NON-SURGICAL TREATMENT MARKET, BY TYPE,
2022–2030 (USD MILLION) 160
TABLE 135 REST OF EUROPE: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 160
TABLE 136 REST OF EUROPE: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION) 161
TABLE 137 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 163
TABLE 138 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 163
TABLE 139 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE,
2022–2030 (USD MILLION) 163
TABLE 140 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS,
BY TYPE, 2022–2030 (USD MILLION) 164
TABLE 141 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION) 164
TABLE 142 ASIA PACIFIC: NON-SURGICAL TREATMENT MARKET, BY TYPE,
2022–2030 (USD MILLION) 164
TABLE 143 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 165
TABLE 144 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER,
2022–2030 (USD MILLION) 165
TABLE 145 CHINA: MACROECONOMIC INDICATORS 166
TABLE 146 CHINA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 166
TABLE 147 CHINA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE,
2022–2030 (USD MILLION) 166
TABLE 148 CHINA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION) 167
TABLE 149 CHINA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT,
2022–2030 (USD MILLION) 167
TABLE 150 CHINA: NON-SURGICAL TREATMENT MARKET, BY TYPE,
2022–2030 (USD MILLION) 167
TABLE 151 CHINA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 168
TABLE 152 CHINA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER,
2022–2030 (USD MILLION) 168
TABLE 153 JAPAN: MACROECONOMIC INDICATORS 169
TABLE 154 JAPAN: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 169
TABLE 155 JAPAN: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE,
2022–2030 (USD MILLION) 169
TABLE 156 JAPAN: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION) 170
TABLE 157 JAPAN: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT,
2022–2030 (USD MILLION) 170
TABLE 158 JAPAN: NON-SURGICAL TREATMENT MARKET, BY TYPE,
2022–2030 (USD MILLION) 170
TABLE 159 JAPAN: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 171
TABLE 160 JAPAN: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER,
2022–2030 (USD MILLION) 171
TABLE 161 INDIA: MACROECONOMIC INDICATORS 172
TABLE 162 INDIA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 172
TABLE 163 INDIA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE,
2022–2030 (USD MILLION) 173
TABLE 164 INDIA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION) 173
TABLE 165 INDIA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT,
2022–2030 (USD MILLION) 174
TABLE 166 INDIA: NON-SURGICAL TREATMENT MARKET, BY TYPE, 2022–2030 (USD MILLION) 174
TABLE 167 INDIA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 174
TABLE 168 INDIA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER,
2022–2030 (USD MILLION) 175
TABLE 169 AUSTRALIA: MACROECONOMIC INDICATORS 175
TABLE 170 AUSTRALIA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 176
TABLE 171 AUSTRALIA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE,
2022–2030 (USD MILLION) 176
TABLE 172 AUSTRALIA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS,
BY TYPE, 2022–2030 (USD MILLION) 176
TABLE 173 AUSTRALIA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT,
2022–2030 (USD MILLION) 177
TABLE 174 AUSTRALIA: NON-SURGICAL TREATMENT MARKET, BY TYPE,
2022–2030 (USD MILLION) 177
TABLE 175 AUSTRALIA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 177
TABLE 176 AUSTRALIA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER,
2022–2030 (USD MILLION) 178
TABLE 177 SOUTH KOREA: MACROECONOMIC INDICATORS 178
TABLE 178 SOUTH KOREA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 179
TABLE 179 SOUTH KOREA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE,
2022–2030 (USD MILLION) 179
TABLE 180 SOUTH KOREA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS,
BY TYPE, 2022–2030 (USD MILLION) 179
TABLE 181 SOUTH KOREA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION) 180
TABLE 182 SOUTH KOREA: NON-SURGICAL TREATMENT MARKET, BY TYPE,
2022–2030 (USD MILLION) 180
TABLE 183 SOUTH KOREA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 180
TABLE 184 SOUTH KOREA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION) 181
TABLE 185 REST OF ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET,
BY PRODUCT, 2022–2030 (USD MILLION) 181
TABLE 186 REST OF ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION) 182
TABLE 187 REST OF ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET
FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION) 182
TABLE 188 REST OF ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET,
BY TREATMENT, 2022–2030 (USD MILLION) 183
TABLE 189 REST OF ASIA PACIFIC: NON-SURGICAL TREATMENT MARKET, BY TYPE,
2022–2030 (USD MILLION) 183
TABLE 190 REST OF ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 183
TABLE 191 REST OF ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET,
BY END USER, 2022–2030 (USD MILLION) 184
TABLE 192 LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 185
TABLE 193 LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 185
TABLE 194 LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION) 185
TABLE 195 LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS,
BY TYPE, 2022–2030 (USD MILLION) 186
TABLE 196 LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION) 186
TABLE 197 LATIN AMERICA: NON-SURGICAL TREATMENT MARKET, BY TYPE,
2022–2030 (USD MILLION) 186
TABLE 198 LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 187
TABLE 199 LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER, 2022–2030 (USD MILLION) 187
TABLE 200 MEXICO: MACROECONOMIC INDICATORS 188
TABLE 201 MEXICO: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 188
TABLE 202 MEXICO: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE,
2022–2030 (USD MILLION) 189
TABLE 203 MEXICO: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION) 189
TABLE 204 MEXICO: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT,
2022–2030 (USD MILLION) 190
TABLE 205 MEXICO: NON-SURGICAL TREATMENT MARKET, BY TYPE,
2022–2030 (USD MILLION) 190
TABLE 206 MEXICO: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 190
TABLE 207 MEXICO: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER,
2022–2030 (USD MILLION) 191
TABLE 208 BRAZIL: MACROECONOMIC INDICATORS 191
TABLE 209 BRAZIL: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 192
TABLE 210 BRAZIL: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE,
2022–2030 (USD MILLION) 192
TABLE 211 BRAZIL: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION) 192
TABLE 212 BRAZIL: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT,
2022–2030 (USD MILLION) 193
TABLE 213 BRAZIL: NON-SURGICAL TREATMENT MARKET, BY TYPE,
2022–2030 (USD MILLION) 193
TABLE 214 BRAZIL: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 193
TABLE 215 BRAZIL: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER,
2022–2030 (USD MILLION) 194
TABLE 216 ARGENTINA: MACROECONOMIC INDICATORS 194
TABLE 217 ARGENTINA: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 195
TABLE 218 ARGENTINA: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE,
2022–2030 (USD MILLION) 195
TABLE 219 ARGENTINA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS,
BY TYPE, 2022–2030 (USD MILLION) 195
TABLE 220 ARGENTINA: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION) 196
TABLE 221 ARGENTINA: NON-SURGICAL TREATMENT MARKET, BY TYPE,
2022–2030 (USD MILLION) 196
TABLE 222 ARGENTINA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 196
TABLE 223 ARGENTINA: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER,
2022–2030 (USD MILLION) 197
TABLE 224 REST OF LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET,
BY PRODUCT, 2022–2030 (USD MILLION) 197
TABLE 225 REST OF LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET,
BY DISEASE, 2022–2030 (USD MILLION) 198
TABLE 226 REST OF LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION) 198
TABLE 227 REST OF LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET,
BY TREATMENT, 2022–2030 (USD MILLION) 199
TABLE 228 REST OF LATIN AMERICA: NON-SURGICAL TREATMENT MARKET, BY TYPE,
2022–2030 (USD MILLION) 199
TABLE 229 REST OF LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 199
TABLE 230 REST OF LATIN AMERICA: PERIODONTAL DISEASE TREATMENT MARKET,
BY END USER, 2022–2030 (USD MILLION) 200
TABLE 231 MIDDLE EAST & AFRICA: PERIODONTAL DISEASE TREATMENT MARKET,
BY PRODUCT, 2022–2030 (USD MILLION) 201
TABLE 232 MIDDLE EAST & AFRICA: PERIODONTAL DISEASE TREATMENT MARKET,
BY DISEASE, 2022–2030 (USD MILLION) 201
TABLE 233 MIDDLE EAST & AFRICA: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION) 201
TABLE 234 MIDDLE EAST & AFRICA: PERIODONTAL DISEASE TREATMENT MARKET,
BY TREATMENT, 2022–2030 (USD MILLION) 202
TABLE 235 MIDDLE EAST & AFRICA: NON-SURGICAL TREATMENT MARKET, BY TYPE,
2022–2030 (USD MILLION) 202
TABLE 236 MIDDLE EAST & AFRICA: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 202
TABLE 237 MIDDLE EAST & AFRICA: PERIODONTAL DISEASE TREATMENT MARKET,
BY END USER, 2022–2030 (USD MILLION) 203
TABLE 238 GCC COUNTRIES: PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 204
TABLE 239 GCC COUNTRIES: PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE, 2022–2030 (USD MILLION) 204
TABLE 240 GCC COUNTRIES: PERIODONTAL DISEASE TREATMENT MARKET FOR GINGIVITIS, BY TYPE, 2022–2030 (USD MILLION) 204
TABLE 241 GCC COUNTRIES: PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT, 2022–2030 (USD MILLION) 205
TABLE 242 GCC COUNTRIES: NON-SURGICAL TREATMENT MARKET, BY TYPE,
2022–2030 (USD MILLION) 205
TABLE 243 GCC COUNTRIES: PERIODONTAL DISEASE TREATMENT MARKET FOR MEDICATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 205
TABLE 244 GCC COUNTRIES: PERIODONTAL DISEASE TREATMENT MARKET,
BY END USER, 2022–2030 (USD MILLION) 206
TABLE 245 PERIODONTAL DISEASE TREATMENT MARKET: DEGREE OF COMPETITION 210
TABLE 246 PERIODONTAL DISEASE TREATMENT MARKET: REGION FOOTPRINT 215
TABLE 247 PERIODONTAL DISEASE TREATMENT MARKET: PRODUCT FOOTPRINT 216
TABLE 248 PERIODONTAL DISEASE TREATMENT MARKET: DISEASE FOOTPRINT 217
TABLE 249 PERIODONTAL DISEASE TREATMENT MARKET: TREATMENT FOOTPRINT 218
TABLE 250 PERIODONTAL DISEASE TREATMENT MARKET: END-USER FOOTPRINT 219
TABLE 251 PERIODONTAL DISEASE TREATMENT MARKET: DETAILED
LIST OF KEY STARTUP/SME PLAYERS 222
TABLE 252 PERIODONTAL DISEASE TREATMENT MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 222
TABLE 253 PERIODONTAL DISEASE TREATMENT MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–OCTOBER 2024 225
TABLE 254 PERIODONTAL DISEASE TREATMENT MARKET: DEALS,
JANUARY 2021–OCTOBER 2024 226
TABLE 255 PERIODONTAL DISEASE TREATMENT MARKET: EXPANSIONS,
JANUARY 2021–OCTOBER 2024 227
TABLE 256 DENTSPLY SIRONA: COMPANY OVERVIEW 228
TABLE 257 DENTSPLY SIRONA: PRODUCTS OFFERED 230
TABLE 258 DENTSPLY SIRONA: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2024 231
TABLE 259 DENTSPLY SIRONA: DEALS, JANUARY 2021–OCTOBER 2024 231
TABLE 260 ENVISTA HOLDINGS CORPORATION: COMPANY OVERVIEW 233
TABLE 261 ENVISTA HOLDINGS CORPORATION: PRODUCTS OFFERED 234
TABLE 262 ENVISTA HOLDINGS CORPORATION: PRODUCT APPROVALS, JANUARY 2021–OCTOBER 2024 235
TABLE 263 ENVISTA HOLDINGS CORPORATION: DEALS 235
TABLE 264 INSTITUT STRAUMANN AG: COMPANY OVERVIEW 237
TABLE 265 INSTITUT STRAUMANN AG: PRODUCTS OFFERED 238
TABLE 266 INSTITUT STRAUMANN AG: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2024 239
TABLE 267 INSTITUT STRAUMANN AG: DEALS, JANUARY 2021–OCTOBER 2024 239
TABLE 268 INSTITUT STRAUMANN AG: EXPANSIONS, JANUARY 2021–OCTOBER 2024 239
TABLE 269 HENRY SCHEIN, INC.: COMPANY OVERVIEW 241
TABLE 270 HENRY SCHEIN, INC.: PRODUCTS OFFERED 242
TABLE 271 HENRY SCHEIN, INC.: DEALS, JANUARY 2021–OCTOBER 2024 243
TABLE 272 BIOLASE INC.: COMPANY OVERVIEW 245
TABLE 273 BIOLASE INC.: PRODUCTS OFFERED 246
TABLE 274 BIOLASE INC.: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2024 247
TABLE 275 GEISTLICH PHARMA AG: COMPANY OVERVIEW 248
TABLE 276 GEISTLICH PHARMA AG: PRODUCTS OFFERED 248
TABLE 277 J. MORITA CORP.: COMPANY OVERVIEW 249
TABLE 278 J. MORITA CORP.: PRODUCTS OFFERED 249
TABLE 279 J. MORITA CORP.: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2024 250
TABLE 280 J. MORITA CORP.: DEALS, JANUARY 2021–OCTOBER 2024 250
TABLE 281 NAKANISHI INC.: COMPANY OVERVIEW 251
TABLE 282 NAKANISHI INC.: PRODUCTS OFFERED 252
TABLE 283 A-DEC INC.: COMPANY OVERVIEW 253
TABLE 284 A-DEC: PRODUCTS OFFERED 253
TABLE 285 RTI SURGICAL: COMPANY OVERVIEW 254
TABLE 286 RTI SURGICAL: PRODUCTS OFFERED 254
TABLE 287 RTI SURGICAL: DEALS, JANUARY 2021–OCTOBER 2024 255
TABLE 288 YOSHIDA DENTAL MFG.CO. LTD.: COMPANY OVERVIEW 256
TABLE 289 YOSHIDA DENTAL MFG.CO. LTD.: PRODUCTS OFFERED 256
TABLE 290 KEYSTONE DENTAL INC.: COMPANY OVERVIEW 257
TABLE 291 KEYSTONE DENTAL INC.: PRODUCTS OFFERED 257
TABLE 292 KEYSTONE DENTAL: DEALS, JANUARY 2021–OCTOBER 2024 258
TABLE 293 ULTRADENT PRODUCTS, INC.: COMPANY OVERVIEW 259
TABLE 294 ULTRADENT PRODUCTS, INC.: PRODUCTS OFFERED 259
TABLE 295 BEGO GMBH & CO. KG: COMPANY OVERVIEW 260
TABLE 296 BEGO GMBH & CO. KG: PRODUCTS OFFERED 260
TABLE 297 BEGO GMBH & CO. KG: DEALS, JANUARY 2021–OCTOBER 2024 261
TABLE 298 DENTALEZ INC.: COMPANY OVERVIEW 262
TABLE 299 DENTALEZ INC.: PRODUCTS OFFERED 262
TABLE 300 DENTALEZ INC.: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2024 263
TABLE 301 PARKELL, INC.: COMPANY OVERVIEW 264
TABLE 302 PARKELL, INC.: PRODUCTS OFFERED 264
TABLE 303 PARKELL, INC.: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2024 265
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN 31
FIGURE 2 PRIMARY SOURCES 33
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 35
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 36
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 36
FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 37
FIGURE 7 INSTITUT STRAUMANN AG: REVENUE SHARE ANALYSIS ILLUSTRATION 38
FIGURE 8 SUPPLY-SIDE ANALYSIS: PERIODONTAL DISEASE TREATMENT MARKET (2023) 39
FIGURE 9 PERIODONTAL DISEASE TREATMENT MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
(2024–2030) 40
FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 40
FIGURE 11 TOP-DOWN APPROACH 41
FIGURE 12 MARKET DATA TRIANGULATION METHODOLOGY 42
FIGURE 13 STUDY ASSUMPTIONS 43
FIGURE 14 PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT,
2024 VS. 2030 (USD MILLION) 45
FIGURE 15 PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE,
2024 VS. 2030 (USD MILLION) 46
FIGURE 16 PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT,
2024 VS. 2030 (USD MILLION) 46
FIGURE 17 PERIODONTAL DISEASE TREATMENT MARKET, BY END USER,
2022 VS. 2029 (USD MILLION) 47
FIGURE 18 GEOGRAPHIC SNAPSHOT OF PERIODONTAL DISEASE TREATMENT MARKET 48
FIGURE 19 INCREASING PREVALENCE OF ORAL DISORDERS TO PROPEL MARKET 49
FIGURE 20 EQUIPMENT SEGMENT IN CHINA ACCOUNTED FOR LARGEST
MARKET SHARE IN 2023 50
FIGURE 21 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 51
FIGURE 22 NORTH AMERICA REGION TO DOMINATE MARKET DURING FORECAST PERIOD 51
FIGURE 23 PERIODONTAL DISEASE TREATMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 52
FIGURE 24 TOTAL DENTAL ENROLLMENT (2011–2020) 60
FIGURE 25 VALUE CHAIN ANALYSIS 63
FIGURE 26 PERIODONTAL DISEASE TREATMENT MARKET: ECOSYSTEM MAP 63
FIGURE 27 PATENT PUBLICATION TRENDS (2013–2024) 70
FIGURE 28 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR PERIODONTAL DISEASE TREATMENT PATENTS (2013–2024) 70
FIGURE 29 TOP 10 APPLICANT COUNTRIES/REGIONS FOR PERIODONTAL DISEASE TREATMENT PATENTS (2013–2024) 71
FIGURE 30 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 74
FIGURE 31 ADJACENT MARKETS FOR PERIODONTAL DISEASE TREATMENT 75
FIGURE 32 PORTER’S FIVE FORCES ANALYSIS 77
FIGURE 33 AVERAGE SELLING PRICE OF PERIODONTAL DISEASE TREATMENT,
BY PRODUCT TYPE 81
FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PERIODONTAL DISEASE TREATMENT 81
FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PERIODONTAL DISEASE TREATMENT 82
FIGURE 36 PERIODONTAL DISEASE TREATMENT MARKET: INVESTMENT & FUNDING SCENARIO, 2021–2024 84
FIGURE 37 NORTH AMERICA: PERIODONTAL DISEASE TREATMENT MARKET SNAPSHOT 128
FIGURE 38 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET SNAPSHOT 162
FIGURE 39 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES 208
FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN PERIODONTAL DISEASE TREATMENT MARKET (2019–2023) 209
FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PERIODONTAL DISEASE TREATMENT MARKET (2023) 210
FIGURE 42 PERIODONTAL DISEASE TREATMENT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 213
FIGURE 43 PERIODONTAL DISEASE TREATMENT MARKET: COMPANY FOOTPRINT 214
FIGURE 44 PERIODONTAL DISEASE TREATMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 221
FIGURE 45 EV/EBITDA OF KEY VENDORS 223
FIGURE 46 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 223
FIGURE 47 PERIODONTAL DISEASE TREATMENT MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL 224
FIGURE 48 R&D EXPENDITURE OF KEY PLAYERS IN PERIODONTAL DISEASE TREATMENT MARKET (2022 VS. 2023) 225
FIGURE 49 DENTSPLY SIRONA: COMPANY SNAPSHOT (2023) 229
FIGURE 50 ENVISTA HOLDINGS CORPORATION: COMPANY SNAPSHOT (2023) 234
FIGURE 51 INSTITUT STRAUMANN AG: COMPANY SNAPSHOT (2023) 238
FIGURE 52 HENRY SCHEIN, INC.: COMPANY SNAPSHOT (2023) 242
FIGURE 53 BIOLASE INC.: COMPANY SNAPSHOT (2023) 246
FIGURE 54 NAKANISHI INC.: COMPANY SNAPSHOT (2023) 251
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11